Latest Breaking News On - Darzalex faspro - Page 1 : comparemela.com

Analysts predict myeloma market will hit $33B by 2030—and tip 1 company to take the lion's share

The multiple myeloma market is booming.

Darzalex-faspro
Pfizer
Bristol-myers-squibb
Johnson
Bristol-myers
Inflation-reduction-act

Pearce IP BioBlast w/e 8 March 2024

On 9 March 2024, Samsung Bioepis presented two papers of study results for its immunology portfolio at the 2024 American Academy of Dermatology (AAD)…

Australia
United-states
France
India
United-kingdom
China
California
Virginia
Canada
Switzerland
San-diego
American

FDA Accepts sBLA for Daratumumab, Hyaluronidase-fihj for Treatment of Multiple Myeloma

Daratumumab and hyaluronidase-fihj in combination with other therapies was previously approved by the FDA in May 2020 for 8 indications in multiple myeloma.

Darzalex-faspro
Craig-tendler
Janssen-biotech-inc
Biologics-license-application
Janssen-biotech
Johnson-innovative-medicine

J&J seeks expanded FDA approval of Darzalex Faspro for multiple myeloma (NYSE:JNJ)

J&J seeks expanded FDA approval of Darzalex Faspro for multiple myeloma (NYSE:JNJ)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Darzalex-faspro
Biologics-license-application
Darzalex-faspro-based

Johnson & Johnson wins arbitration appeal against Genmab

Johnson & Johnson wins arbitration appeal against Genmab
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Denmark
Danish
Darzalex-faspro
Silicon-valley
Stock-editorial
Halozyme-therapeutic